Back
Inhibrx Biosciences Vs. Protalix BioTherapeutics Industry Stock Comparison
Buy
54
INBX
Inhibrx Biosciences
Last Price:
13.96
Seasonality Move:
--
Buy
80
PLX
Protalix BioTherapeutics
Last Price:
1.67
Seasonality Move:
78.33%
Buy
54
Inhibrx Biosciences (INBX)
is a Buy
Is Inhibrx Biosciences a Buy, Sell or Hold?
- The current Inhibrx Biosciences [INBX] share price is $14.04. The Score for INBX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- INBX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.69. The Score for PLX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INBX Stock Price Chart
What is Inhibrx Biosciences's stock price today?
-
The Inhibrx Biosciences share price today is $14.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX is experiencing slight selling pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.69
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 37.96 | Sell |
| Chaikin Money Flow: | -41514 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.71 - 16.33) | Sell |
| Bollinger Bands (100): | (13.09 - 16.09) | Sell |
PLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 76 | Buy |
| Chaikin Money Flow: | 188555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.43) | Buy |
| Bollinger Bands (100): | (0.96 - 1.24) | Buy |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.77 | Sell |
| 20-day SMA: | 15.44 | Sell |
| 50-day SMA: | 15.68 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 14.58 | Sell |
| 20-day EMA: | 15.15 | Sell |
| 50-day EMA: | 15.29 | Sell |
| 200-day EMA: | 2.13 | Buy |
PLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.44 | Buy |
| 20-day SMA: | 1.28 | Buy |
| 50-day SMA: | 1.15 | Buy |
| 200-day SMA: | 1.19 | Buy |
| 8-day EMA: | 1.49 | Buy |
| 20-day EMA: | 1.33 | Buy |
| 50-day EMA: | 1.2 | Buy |
| 200-day EMA: | 1.22 | Buy |
Inhibrx Biosciences Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Inhibrx Biosciences Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protalix BioTherapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||